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Preoperative portal vein embolization (PVE) is used to extend the indications for major 
hepatic resection, and it has become the standard of care for selected patients with 
hepatic malignancies treated at major hepatobiliary centers. To date, various techniques 
with different embolic materials have been used with similar results in the degree of liver 
hypertrophy. Regardless of the specific strategy used, both surgeons and interventional 
radiologists must be familiar with each other’s techniques to be able to create the opti-
mal plan for each individual patient. Knowledge of the segmental anatomy of the liver 
is paramount to fully understand the liver segments that need to be embolized and 
resected. Understanding the portal vein anatomy and the branching variations, along 
with the techniques used to transect the portal vein during hepatic resection, is import-
ant because these variables can affect the PVE procedure and the eventual surgical 
resection. Comprehension of the advantages and disadvantages of approaches to the 
portal venous system and the various embolic materials used for PVE is essential to best 
tailor the procedures for each patient and to avoid complications. Before PVE, meticu-
lous assessment of the portal vein branching anatomy is performed with cross-sectional 
imaging, and embolization strategies are developed based on the patient’s anatomy. The 
PVE procedure consists of several technical steps, and knowledge of these technical 
tips, potential complications, and how to avoid the complications in each step is of 
great importance for safe and successful PVE and ultimately successful hepatectomy. 
Because PVE is used as an adjunct to planned hepatic resection, priority must always 
be placed on safety, without compromising the integrity of the future liver remnant, and 
close collaboration between interventional radiologists and hepatobiliary surgeons is 
essential to achieve successful outcomes.
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iNTRODUCTiON
With increasing understanding of liver vascular and biliary 
anatomy, advancements in surgical techniques, and use of intra-
operative liver ultrasound, the safety of major hepatic resection 
has dramatically improved over the last few decades. Major 
hepatic resections are currently being performed at numerous 
hepatobiliary centers worldwide, with operative mortality rates 
of less than 2% (1, 2). Although surgical resection offers the best 
opportunity for long-term survival with the potential for cure 
in appropriately selected patients, extensive surgical resection 
can be associated with postoperative liver failure because of 
inadequate functional liver volume after surgery, especially when 
underlying liver disease is present and the extent of liver resection 
is significant.
Preoperative portal vein embolization (PVE) was developed 
to extend the indications for major hepatic resection, and it has 
become the standard of care for selected patients with hepato-
biliary malignancies. By interrupting all of the portal vein flow 
to the diseased liver to be resected, this technique can induce 
atrophy of the diseased liver through removal of its primary blood 
supply, and through the release of specific hormones and growth 
factors (3–5), lead to hypertrophy of the non-diseased liver that 
will remain in  situ after surgery [i.e., the future liver remnant 
(FLR)]. PVE also causes a shift in the function of the liver to the 
FLR and allows the patient to preoperatively adjust to changes in 
portal pressure to decrease the morbidity of the resection (6). The 
resultant increase in the functional volume of the FLR is geared 
to convert patients with unresectable disease into resection 
candidates, specifically by lowering the risk of postoperative liver 
insufficiency and failure (3, 5, 7, 8). In addition, the experience 
published at multiple centers worldwide has now established this 
technique to be safe and carry minimal morbidity (6, 9).
The indications for PVE depend upon the degree of under-
lying liver dysfunction and the extent of anticipated resection. 
Guidelines include for PVE to be performed when the FLR is 
anticipated to be ≤20% in normal livers, ≤30% in diseased liv-
ers or those in which chemotherapy-associated steatohepatitis 
(CASH) is suspected, and ≤40% in cirrhotic livers to reach those 
respective targets (6, 10). In addition, a degree of hypertrophy of 
at least 5% has been shown to predict outcome (6). Previous stud-
ies have determined that the FLR standardized to the patient’s 
size offers a good estimate of the functional liver volume; this is 
calculated with the FLR measured using computed tomography 
(CT) volumetry and calculating its contribution to the total liver 
volume as a proportion of the estimated total liver volume derived 
from the patient’s body surface area (BSA):
 
standardized FLR sFLR
FLR volume measured from CT
estimat
( )
( )
=
ed total liver volume (ETLV)  
where ETLV = [−794.41 + 1267.28 × BSA in square meters].
This method limits inaccuracies related to the diseased liver 
(11, 12).
At present, there is no standardized technique used for PVE. 
Various techniques, with different embolic materials, have been 
used, without significant differences in the degree or rate of liver 
hypertrophy (9). Regardless of the techniques used, both surgeons 
and interventional radiologists must have essential knowledge 
universally applicable to PVE to communicate with each other 
and achieve successful outcomes for patients. First, a thorough 
knowledge of segmental liver anatomy and of the terminology 
used for hepatic resections is important to understand fully 
the segments that need to be embolized for anticipated hepatic 
resection. Second, knowledge of portal vein anatomy, especially 
that of the branching variations, is paramount to correctly select 
portal vein branches to embolize. Finally, knowledge of surgical 
techniques used for the anticipated hepatic resection is required 
because PVE performed without such knowledge can potentially 
render subsequent surgical procedures difficult, more risky, and/
or occasionally result in the inability to accomplish a safe resection.
In this article, we review hepatic segmental anatomy and the 
terminology used for hepatic resections, portal vein anatomy, and 
branching variations, and the surgical techniques used for major 
hepatic resection. We discuss strategies for PVE based on portal 
vein anatomy and preprocedural planning with cross-sectional 
imaging. We also review and discuss approaches to the portal 
venous system, the embolic materials used, and the techniques 
and technical tips for safe and successful PVE. Finally, additional 
strategies or technical modifications that might be required dur-
ing PVE are described.
HePATiC SeGMeNTAL ANATOMY AND 
TeRMiNOLOGY USeD FOR HePATiC 
ReSeCTiONS
The liver consists of eight functional segments, which have their 
own hepatic arterial and portal venous supply, biliary drainage, 
and hepatic venous drainage. As major hepatic resections require 
transection of the hepatic parenchyma along the boundaries 
of these segments (i.e., anatomic resection), understanding 
the hepatic segmental anatomy and the terminology used for 
segment-oriented hepatic resections is a prerequisite for PVE.
Several classification systems of liver segmentation have 
been proposed and used without a standardized terminology to 
describe the liver segments. Healey and Schroy (13) divided the 
liver into five segments based on second-order branching patterns 
of the hepatic arteries and bile ducts. Couinaud (14), whose clas-
sification system is likely the most commonly used worldwide, 
divided the liver into eight segments based on third-order portal 
vein branching. Goldsmith and Woodburne (15) also advocated 
division of the liver based on the portal vein branching; however, 
they described four segments based on second-order portal vein 
branching. Different terminology to describe the same functional 
unit of the liver, used by different researchers or anatomists, has 
resulted in much confusion among clinicians. In 2000, the termi-
nology committee of the International Hepato-Pancreato-Biliary 
Association (IHPBA) proposed a standardized terminology 
for liver segmentation and hepatic resections during the World 
Congress of the IHPBA in Brisbane, Australia (16). In this pro-
posal, the segmental liver anatomy was described according to the 
first-, second-, and third-order branching patterns of the hepatic 
FiGURe 1 | illustration of the segmental anatomy of the liver based on 
the third-order portal vein branching (Couinaud’s classification 
system) and the portal vein and hepatic vein branches. IVC: inferior 
vena cava and PV: portal vein.
FiGURe 2 | Representative hepatic resections. (A) Right hepatectomy or right hemihepatectomy (resection of segments 5–8) and left hepatectomy or left 
hemihepatectomy (resection of segments 2–4). (B) Right trisectionectomy or extended right hepatectomy (resection of segments 4–8) and left lateral sectionectomy 
or bisegmentectomy 2 and 3 (resection of segments 2 and 3). (C) Segmentectomy 6 (resection of segment 6). (D) Bisegmentectomy 5 and 6 (resection of 
segments 5 and 6).
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arteries and bile ducts. The term “segment” (Sg) was restricted 
to indicating the third-order division, as in Couinaud segments 
1–8 (Figure 1). The first-order division divides the liver into the 
left and right hemiliver or the left and right liver. The border, also 
called a watershed, of the first-order division is referred to as the 
midplane of the liver, which is defined by the plane between the 
inferior vena cava and the gallbladder fossa, also known as Cantlie’s 
line. The new term “section,” which is equivalent to “sector” in 
Couinaud’s classification system, was introduced to indicate the 
second-order division. The second-order division divides the liver 
into four sections. The right liver is divided into the right anterior 
section (Sg 5 and 8) and the right posterior section (Sg 6 and 7). 
The left liver is divided into the left lateral section (Sg 2 and 3) and 
the left medial section (Sg 4). The third-order division refers to the 
individual segments of the liver. The segments are referred to as 
segments 1–8. The segments are divided by intersegmental planes, 
which represent the borders of the segments.
The terminology of hepatic resections is based directly on the 
anatomic terminology used in this proposal (Figure 2). Resection 
at the first-order division is called right or left hepatectomy or 
hemihepatectomy. Resection of a single section is referred to as 
sectionectomy (i.e., left lateral sectionectomy). Extended resec-
tions of three sections are called trisectionectomies (or extended 
hepatectomies/hemihepatectomies). Resection of a single seg-
ment is referred to as segmentectomy (i.e., segmentectomy 6), 
and resection of any two contiguous segments is referred to as 
a bisegmentectomy (i.e., bisegmentectomy 5 and 6) (16). When 
segment 1 is resected as part of the procedure, it should be stated 
as in the following examples: “left hepatectomy with resection 
of segment 1” or “left hepatectomy extended to segment 1.” The 
Brisbane 2000 terminology of liver anatomy and resections has 
been increasingly used in the literature worldwide (17); adher-
ence to this terminology is encouraged to avoid confusion when 
referring to liver segments or hepatic resections.
NORMAL PORTAL ANATOMY AND 
PORTAL BRANCHiNG vARiATiONS
In standard portal vein anatomy, the main portal vein ascends 
through the hepatoduodenal ligament and typically divides at 
FiGURe 3 | Standard portal vein branching and main portal vein 
branching variations. (A) Standard portal vein branching. (B) Trifurcation of 
the main portal vein. (C) The right posterior portal vein arising as the first 
branch of the main portal vein. MPV, main portal vein; LPV, left portal vein; 
RPV, right portal vein; RAPV, right anterior portal vein; and RPPV, right 
posterior portal vein.
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the hepatic hilum into the left and right portal veins. The left 
portal vein courses medially to the umbilical fissure, forming 
the horizontal part (pars transversa), and then turns anteriorly 
to form the umbilical part (pars umbilicalis). The left portal vein 
gives off the branches supplying Sg 2 (Sg 2 branch) and Sg 3 and 4. 
The right portal vein gives rise to the right anterior and posterior 
portal veins, which supply the anterior and posterior sections, 
respectively. The right anterior portal vein further divides into 
the Sg 5 and 8 branches, while the right posterior portal vein 
divides into the Sg 6 and 7 branches (Figure 3A). This standard 
portal vein anatomy is observed in approximately 65–80% of the 
population, and any deviation from this anatomy is considered to 
be a branching variation (18–20).
The most common main portal vein branching variations are 
trifurcation of the main portal vein (Figure  3B) and the right 
posterior portal vein arising as the first branch of the main portal 
vein (Figure 3C). The reported incidence of these branching vari-
ations has ranged from 8 to 23% (18, 19, 21, 22). Quadrification, 
in which the main portal vein divides into the left portal vein, 
right anterior portal vein, and Sg 6 and 7 branches, can occur, 
but it is quite uncommon. Other rare main portal vein variations 
have been described, including duplication or absence of the right 
portal vein, which is associated with a hypoplastic right liver and 
absence of the horizontal part of the left portal vein, in which a 
single portal vein enters the right liver and courses to the left, 
giving only segmental branches along its course (23).
Various branching variations of the right portal vein have been 
reported, with incidences ranging from 17 to 35% (19, 24, 25). 
The most common variations are trifurcation of the right portal 
vein and proximal origin of a segmental branch from the right 
portal vein. The right portal vein has been reported to trifurcate 
in several ways; however, the most common type is trifurcation 
into the right anterior portal vein and Sg 6 and 7 branches without 
a common trunk of the right posterior portal vein (Figure 4A) 
(18, 19, 25). Other types of trifurcation may be encountered, 
such as division into the right posterior portal vein and Sg 5 
and 8 branches (Figure 4B); right anterior and posterior portal 
veins and a separate common trunk of the Sg 5 and 6 branches; 
or right anterior or posterior portal veins and separate Sg 5, 6, 
or 8 branches (Figure  4C); however, these variations are less 
frequent (19, 25). Rarely, the right portal vein divides into four 
separate segmental branches (Sg 5–8) without a common trunk 
of the right anterior and posterior portal veins (Figure 4D). A 
segmental or subsegmental branch can often originate from the 
right portal vein, proximal to the bifurcation of the right anterior 
and posterior portal veins. Of the segmental branches originating 
from the right portal vein, the Sg 6 and 7 branches are the most 
commonly observed (Figures 4E,F). The subsegmental branches 
supplying segments 5–8 can also originate from the right portal 
vein (Figures 4G,H).
The portal vein branches crossing the midplane of the 
liver (which separates the right and left liver) are rare, but 
they are very important to recognize prior to PVE. If these 
branches are unrecognized, the left portal vein branches 
that supply the diseased right liver can be inadvertently left 
unembolized, or conversely, the right portal vein branches 
that supply the non-diseased left liver can be inadvertently 
embolized during right PVE (embolization of Sg 5–8). In a 
portal vein anomaly, in which the ligamentum teres is devi-
ated to the right and is juxtaposed to the gallbladder, the 
right anterior portal vein arises from the rightward-deviated 
umbilical portion of the left portal vein (Figure 5) (26). In 
this anomaly, the main portal vein first gives off the right 
posterior portal vein, courses cranially without forming the 
horizontal part, and terminates at the rightward-deviated 
umbilical portion. This anomaly has been reported to be 
encountered in less than 1% of patients. Some authors have 
referred to this anomaly as “fusion of hepatic planes,” as 
they hypothesize that this anomaly is caused by fusion of the 
midplane of the liver with the left intersectional plane due 
to incomplete development of the central part of the liver 
(27, 28). A segmental or subsegmental portal vein branch 
can also cross the midplane of the liver (Figure 6). The Sg 8 
branch can arise from the left portal venous system, or the 
Sg 4 branch can arise from the right portal venous system. 
Very rarely, the Sg 6 or 7 branch arises from the left portal 
FiGURe 4 | Right portal vein branching variations. (A–C) Trifurcation of the right portal vein. (D) Quadrification of the right portal vein. (e,F) Proximal origin of the 
segmental branch from the right portal vein. (G,H) Proximal origin of the subsegmental branch from the right portal vein.
FiGURe 5 | Drawing illustrates the right anterior portal vein that arises 
from the left portal vein in an anomaly with the right-sided 
ligamentum teres that is juxtaposed to the gallbladder. In this anomaly, 
the umbilical portion of the left portal vein is also deviated to the right. UP, 
umbilical portion; LT, ligamentum teres (dotted line); and GB, gall bladder.
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venous system (25). The diameters of these variant branches 
have been reported to range from 0.5 to 2.7 mm, and these 
branches are encountered in less than 4% of patients (22).
SURGiCAL TeCHNiQUeS USeD FOR 
MAJOR HePATiC ReSeCTiON
For those patients receiving preoperative PVE, the most common 
resection is either a right hepatectomy (resection of Sg 5–8) or a 
right trisectionectomy (resection of Sg 4–8). Patients undergoing 
hepatic resections other than these two resections do not usu-
ally require preoperative PVE because they will normally have 
a sufficiently functional FLR, which does not necessitate PVE. 
Left trisectionectomy (Sg 2–5 and 8) only rarely requires preop-
erative PVE, most commonly when performed on patients with 
liver disease. Therefore, the surgical techniques used for right 
hepatectomy and right trisectionectomy will be discussed herein. 
Because a review of the technical details of hepatic resections is 
beyond the scope of this article, only the essential technical steps, 
especially those relevant to PVE, are highlighted.
Although there are many different techniques and sequences 
used for major hepatic resections, any anatomic hepatic resection 
is generally performed according to three principles: (1) control 
of inflow (portal vein and hepatic artery – and biliary ducts) to the 
FiGURe 6 | Segmental or subsegmental portal vein branches that cross the midplane of the liver. (A) A Sg 4 branch that arises from the right anterior 
portal vein. (B) A Sg 8 branch that arises from the left portal vein. (C) A subsegmental branch that arises from the right anterior portal vein but supplies Sg 4. (D) A 
subsegmental branch that arises from the left portal vein but supplies Sg 8.
FiGURe 7 | Surgical techniques used for the control of inflow to the liver in a right hepatectomy. (A) Extrahepatic dissection and ligation. The hilar plate 
(arrow) is dissected and the right hepatic artery and right portal vein are ligated and dissected individually. A vascular stapler is used to divide the right portal vein. 
(B) Intrahepatic pedicle ligation. Arrow indicates the site of a hepatotomy made at the inferior surface of the liver to expose the intrahepatic main right portal pedicle. 
A vascular stapler which is inserted into the liver parenchyma divides the main right portal pedicle.
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liver, (2) control of outflow (hepatic vein) from the liver, and (3) 
parenchymal transection (29). Control of inflow to the liver can 
be achieved extrahepatically at the hepatic hilum (extrahepatic 
dissection and ligation). The thick connective tissue that wraps 
around the portal vein, hepatic artery, and bile duct at the hepatic 
hilum (hilar plate) is dissected first. The right hepatic artery 
and right portal vein are then isolated and ligated individually 
(Figure 7A). This is the classic approach to inflow vessel control. 
Alternatively, inflow to the liver can be controlled intrahepatically 
through a hepatotomy made at the inferior surface of the liver 
to access the portal pedicle within the liver (intrahepatic pedicle 
ligation/intrahepatic Glissonian approach). The portal pedicle or 
Glissonian pedicle is a vascular pedicle that contains the portal 
triad. This pedicle is wrapped with thick connective tissue that is 
contiguous with the hilar plate. Because the portal pedicle ramifi-
cates within the liver to supply the segment or section into which 
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the pedicle enters, any segment or section can be safely resected 
by ligation of its corresponding pedicle (30). In a right hepatec-
tomy, the right main portal pedicle within the liver parenchyma is 
isolated and ligated (Figure 7B). A vascular stapler is often used 
to divide the portal pedicle. Intrahepatic pedicle ligation offers 
some advantages over the extrahepatic dissection and ligation 
because it eliminates the need for hilar dissection and reduces the 
risk of injury to the vessels or biliary drainage of the contralateral 
liver. When performing PVE, care must be taken to avoid placing 
embolic material, such as coils, in locations that may limit the sur-
geon’s ability to divide the portal vein at the desired location. For 
instance, if the surgeon routinely uses an extrahepatic dissection 
and ligation technique, it is helpful to leave the proximal 1-cm 
portion of the right portal vein free of embolic material so that 
the right portal vein can be easily ligated and divided. Surgeons 
who use an intrahepatic pedicle ligation technique might prefer 
to ligate the right anterior and posterior portal pedicles individu-
ally. In such cases, embolic materials should not be left within 
the proximal right anterior or posterior portal veins. Conversely, 
the surgeon needs to be knowledgeable and cognizant about the 
location of the coils and embolic material, as if the PVE procedure 
did not allow to place the embolic material in the specific desired 
location, as described, the surgeon will need to adjust the surgical 
technique to accomplish the desired resection in a safely man-
ner. Therefore, knowledge of the inflow control technique the 
surgeon plans to use during the procedure and understanding 
details of the PVE procedure performed by the interventional 
radiologist are both critical pieces of information when planning 
PVE and subsequent surgery; and discussion between the two 
parties regarding the most proximal site of the portal veins into 
which embolic materials can be placed is mandatory prior to 
PVE. Control of outflow from the liver is performed by isolating 
and dividing the right hepatic vein and the small hepatic veins 
that drain directly into the inferior vena cava. Once inflow to 
and outflow from the liver are controlled, the liver is transected 
along the line demarcated by the devascularization of the right 
hemiliver resulting from division of the right hepatic artery and 
right portal vein (parenchymal transection). Some surgeons may 
control inflow during parenchymal transection by dividing portal 
pedicles with a vascular stapler as they are encountered during 
transection. In this technique, the hepatotomy at the inferior 
surface of the liver to isolate the right main portal pedicle is not 
necessary.
In right trisectionectomy, the initial steps are the same as with 
right hepatectomy, up through control of inflow to and outflow 
from the liver. The next step involves selective ligation of the portal 
pedicles supplying Sg 4. The liver parenchyma is then transected 
immediately to the right of the falciform ligament. The middle 
hepatic vein is generally left intact until it is encountered in the 
upper part of the dissection, at which point it is either suture- or 
staple-ligated.
eMBOLiZATiON STRATeGieS BASeD ON 
PORTAL BRANCHiNG ANATOMY
In general, strategies for PVE are devised based on the type of 
surgery planned, the surgeon’s preference for the technique used 
for vascular inflow control (extrahepatic vs. intrahepatic), and 
the portal branching anatomy. If right hepatectomy is planned, 
many authors have recommended that a proximal right portal 
vein at least 1  cm in length remain patent to facilitate hepatic 
resection (31, 32). This recommendation also reduces the risk of 
propagation of right portal vein thrombus to the left portal vein. 
In standard portal vein anatomy, in which the main portal vein 
divides into the right and left portal veins, the length of the right 
portal vein ranges from 0.5 to 2.3 cm (33, 34). If the length of 
the right portal vein is greater than 1 cm, the most proximal site 
where the embolic material should be placed is within the distal 
right portal vein (Figure 8A). If the length of the right portal vein 
is less than 1 cm, the right anterior and posterior branches must 
be embolized individually (Figure 8A). Individual embolization 
of the right anterior and posterior branches might also be neces-
sary if the surgeon prefers the entire right portal vein to be patent 
or if he or she uses the intrahepatic pedicle ligation technique, in 
which the distal right portal vein is normally ligated.
For patients with portal vein branching variations, different 
strategies are required. For instance, in patients with main portal 
vein trifurcation in which no right portal vein exists, the right 
anterior and posterior portal veins must be embolized indi-
vidually, with at least a 1-cm proximal portion remaining patent 
(Figure  8B). In patients with a segmental branch arising from 
the right portal vein, this branch usually needs to be embolized 
separately, especially when the branch arises from the proximal 
1-cm portion of the right portal vein (Figure 8C).
APPROACHeS TO THe PORTAL veNOUS 
SYSTeM
Access to the portal venous system can be accomplished by any 
of three approaches: transhepatic contralateral, transhepatic 
ipsilateral, and transileocolic approaches. Each approach has 
its own advantages and disadvantages (Table  1). The choice of 
the approach can depend on the type of surgery planned, the 
embolic material used, the operator’s preference, and the level of 
the operator’s experience with one approach over the others.
The transhepatic contralateral approach involves punctur-
ing the portal vein branch within the FLR under ultrasound 
guidance. The catheter is then advanced into the portal venous 
system within the diseased liver for embolization. When right 
PVE (embolization of Sg 5–8) is performed, this approach allows 
for technically smooth cannulation of the right portal vein 
from the left liver. If N-butyl cyanoacrylate (NBCA) is used for 
embolization, this approach is desirable because NBCA can be 
delivered to the distal portal branches in an antegrade manner, 
without the risk of catheter entrapment within the portal venous 
system. A final portogram can be obtained with a minimal risk 
of dislodging the embolic material. In addition, there is no 
theoretical risk of puncturing the tumor tissue, which can result 
in bleeding or tumor seeding. One major disadvantage of this 
approach is the potential risk of damaging the FLR parenchyma 
and the left portal vein because of direct puncture of and instru-
mentation within the portal vein in the FLR. Should these events 
occur, the anticipated hepatic resection could become difficult 
FiGURe 8 | Right Pve strategies based on portal vein branching anatomy. In each drawing, black lines indicate the most proximal site or sites where embolic 
materials can be placed when the length of the right portal vein is more than 1 cm. The dotted black lines indicate the most proximal site or sites where embolic 
materials can be placed when no right portal vein exists or the length of the right portal vein is less than 1 cm. (A) A case with standard portal vein anatomy. (B) A 
case with trifurcation of the main portal vein. (C) A case with a Sg 6 branch arising from the proximal 1-cm portion of the right portal vein.
TABLe 1 | Characteristics of three approaches used for Pve.
Approach to the portal 
system
Technique Advantages Disadvantages
Contralateral approach Transhepatic portal vein 
cannulation within the  
non-diseased liver (FLR)
Easy catheter manipulation within the 
diseased liver
Potential damage to the FLR during portal access or 
catheter manipulation
Theoretically no risk of dislodging embolic 
materials during final portography
Difficult cannulation of Sg 4 portal branches for 
embolization when a right trisectionectomy is anticipated
Ipsilateral approach Transhepatic portal vein 
cannulation within the 
diseased liver to be resected
Theoretically no risk of damage to the 
FLR related to portal access or catheter 
manipulation
Technically challenging catheter manipulation within the 
portal branches in the diseased liver
Possible migration of embolic materials into the FLR during 
final portography
Transileocolic approach Direct cannulation of 
the ileocolic vein during 
laparotomy
Accurate assessment of peritoneal seeding 
and disease extension to the FLR
Theoretically no risk of damaging the FLR, 
hemoperitoneum, or subcapsular hematoma
Most invasive
Requires general anesthesia
Exposed to post-laparotomy complications
FLR, future liver remnant.
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or even impossible. When this approach is used, great care must 
be exercised to limit the number of punctures of the portal vein 
branch, and gentle catheter manipulation within the FLR is 
mandatory. Tract embolization is not usually performed to avoid 
non-targeted embolization.
The transhepatic ipsilateral approach involves puncturing the 
portal vein branch within the diseased liver to be resected under 
ultrasound or fluoroscopic guidance. The main advantage of this 
approach is the much lower risk of damaging the FLR compared 
to the contralateral approach because the FLR is not punctured 
and instrumented. With this approach, the complications that 
can arise from the PVE procedure rarely result in abandonment 
of the planned hepatic resection. An additional advantage of the 
ipsilateral approach is technically easier catheterization of Sg 4 
TABLe 2 | Characteristics of embolic materials used for Pve.
embolic material Advantages Disadvantages Other characteristics
NBCA Durable portal occlusion that lasts for 
more than 4 weeks
Peribiliary fibrosis and casting of the portal vein that could 
increase surgical difficulty
Mixed with ethiodized oil at a ratio 
of 1:1–1:3
Can be associated with a shorter 
procedure time than with other materials
Requires a high level of experience
Difficult to use in patients with reduced hepatopetal flow
Microparticles (PVA 
or microspheres)
Durable portal occlusion if used with coils Usually requires many bottles if small-sized particles are 
used alone
Frequently used with coils to occlude 
proximal portal veinsEasy to administer
Minimal periportal reaction
Absolute ethanol Durable portal occlusion Requires an occlusion balloon catheter to administer Good hypertrophy reported in 
patients with chronic liver diseaseCauses hepatocyte necrosis, resulting in transaminase and 
bilirubin elevation
Less patient tolerability because of associated pain
Gelatin sponge/
Gelfoam®
Easy to administer Associated with a high rate of portal recanalization if used 
alone
Can be mixed with ethiodized oil or 
thrombinInexpensive
Minimal periportal reaction
Fibrin glue Reported favorable rates of hypertrophy in 
Eastern countries
Requires a special balloon catheter with separate lumen to 
administer
Mixture with ethiodized oil necessary 
for radiopacity
Portal recanalization can occur within 4 weeks if used alone
NBCA, N-butyl cyanoacrylate; PVA, polyvinyl alcohol.
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compared to the contralateral approach, when Sg 4 needs to be 
embolized. The disadvantages of the ipsilateral approach include 
technically difficult cannulation of the right portal vein branches 
because of acute angulations between the branches and the risk 
of migration of embolic material during the final portography or 
catheter removal. To overcome the difficult cannulation of the 
right portal vein branches, a reverse curve catheter or an occlu-
sion balloon catheter with multiple lumens is usually needed. 
Great care must be exercised not to dislodge the embolic material 
during or after embolization of the portal vein branches.
The transileocolic approach involves a laparotomy focused on 
the right lower quadrant and direct cannulation of the ileocolic 
vein. The catheter is advanced into the portal vein branches 
through the main portal vein for embolization. This approach 
was the original PVE method used by surgeons; however, it has 
not gained widespread use with the development of percutaneous 
transhepatic approaches. Although the transileocolic approach 
has several disadvantages that inherently arise from a laparotomy, 
it has some advantages over the transhepatic approaches. This 
approach enables the operator to detect peritoneal seeding and 
additional staging procedures, which may result in advanced 
disease beyond a stage amenable to surgical treatment, and hence 
making the PVE itself and the planned surgery unnecessary (35). 
In cases with multiple or large liver tumors, the transileocolic 
approach might be ideal to avoid puncturing the tumors while 
obtaining portal access.
eMBOLiC MATeRiALS USeD FOR Pve
Knowledge of the embolic materials available for PVE is a pre-
requisite for secure, durable embolization without complications. 
A broad spectrum of embolic materials have been used, includ-
ing NBCA, absolute ethanol, microparticles, gelatin sponge or 
Gelfoam®, fibrin glue, or combinations of these materials with 
coils or vascular plugs. Their advantages and disadvantages when 
used for PVE and other characteristics are shown in Table 2. In 
animal models, several researchers have demonstrated the signifi-
cant differences in the degrees of hepatocyte proliferation among 
various embolic materials (36, 37). However, neither clinical 
studies have revealed significant differences in the efficacy of one 
embolic material over another in inducing liver hypertrophy nor 
have differences in complication rates been demonstrated among 
the various embolic materials. Currently, there is no consensus 
regarding the best embolic material for PVE (38). Rather, the 
choice of embolic material is based on the operator’s preference 
and experience with embolic material, the catheter available for 
the delivery of the embolic material, or the approach to the portal 
venous system used for PVE.
N-butyl cyanoacrylate is a radiolucent liquid agent that 
polymerizes within seconds in ionic solutions, such as blood. 
NBCA is mixed with ethiodized oil, normally at a ratio of 
1:1–1:3, for slower polymerization and radiopacity. By changing 
the NBCA-to-ethiodized oil ratio, the time to polymerization can 
be adjusted, depending on the portal flow velocity and the order 
of the portal veins targeted for embolization. To embolize distal 
portal vein branches, a higher ratio mixture is used as opposed 
to a lower ratio mixture to embolize the proximal portal vein 
branches. The delivery catheter must be frequently flushed with 
a non-ionic solution (such as 5% dextrose) to prevent occlusion 
of the catheter lumen. Several clinical studies have shown that 
embolization with NBCA results in fast, reliable, and long-term 
portal occlusion and leads to good hypertrophy of the FLR (39, 
40); however, use of NBCA requires considerable technical 
expertise and can make subsequent hepatic surgery challenging 
due to the significant periportal inflammation it causes. Absolute 
ethanol is a strong sclerosant and causes protein denaturation and 
coagulation. Embolization with absolute ethanol has been shown 
to produce reliable hypertrophy of the FLR, even in patients with 
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chronic liver disease (41, 42). However, absolute ethanol can cause 
significant periportal necrosis and fibrosis and greater alteration 
in measured liver function tests can result when compared to 
PVE with other embolic materials. Potential systemic effects 
with absolute ethanol, such as intoxication or abdominal pain, 
might be associated with poor patient tolerance. Microparticles, 
such as polyvinyl alcohol (PVA) or tris-acryl microspheres, can 
accurately target the vessels to be occluded within the vascular 
network in the tumor or organ. Microparticles are available in a 
variety of sizes, mostly ranging from 100 to 1200 μm in diameter. 
They are generally easy to use, cause minimal periportal reaction, 
and generate durable portal occlusion when used in combination 
with coils (43). The theoretical benefit of using this embolic mate-
rial is a smaller chance of developing a collateral blood supply 
within the embolized segments because of distal portal branch 
embolization. Gelatin sponge or Gelfoam® is a water-insoluble 
temporary embolic material that can be used as a form of inject-
able pledgets or slurry. This material, which is used as a hemo-
static device, is widely available and inexpensive. If used alone, 
recanalization can occur in 2  weeks after PVE and inadequate 
hypertrophy can result from embolization with gelatin sponge 
(44, 45). However, when combined with other embolic materials, 
such as polidocanol or ethiodized oil, favorable hypertrophy rates 
comparable to those observed with other embolic materials have 
been reported (46, 47). Fibrin glue, a mixture of fibrinogen and 
thrombin, was designed to mimic the final steps of the coagula-
tion cascade and forms stable, physiological fibrin clots that assist 
hemostasis. It is used with ethiodized oil to confer radiopacity. 
Hypertrophy rates comparable to the rates measured with other 
embolic materials have been reported (31, 48). However, a spe-
cialized balloon catheter, with separate lumens for the delivery of 
both fibrinogen and thrombin, is necessary to administer fibrin 
glue, and this catheter is not available worldwide. Finally, foam 
sclerotherapy using polidocanol has recently been reported to be 
safe and effective for PVE (49). In the study, polidocanol foam 
was administered into the targeted vessels through the occlusion 
balloon catheter. Because of polidocanol’s anesthetic effect, PVE 
with polidocanol foam was well tolerated without pain and the 
sufficient degrees of liver hypertrophy that are comparable to 
those reported with other embolic materials were observed.
PRePROCeDURAL PLANNiNG wiTH 
CROSS-SeCTiONAL iMAGiNG
As applicable to all complex interventional procedures, preproc-
edural planning with cross-sectional imaging is a prerequisite for 
successful PVE. Multiphasic multidetector-row CT or dynamic 
contrast-enhanced magnetic resonance imaging is usually 
obtained before PVE to evaluate the extent of the liver disease 
and to measure the volume of the FLR. The portal and hepatic 
vein anatomy is assessed, and the segments to be resected are 
confirmed. Portal vein variations relevant to anticipated PVE 
are identified. Attention must be paid to identify any portal vein 
branches that cross the midplane of the liver or intersegmental 
boundaries. As discussed in the previous section, the portal 
branches that supply the liver segments to be resected but that 
arise from the FLR can be easily left unembolized, or conversely, 
the branches that supply the FLR but that arise from the liver seg-
ments to be resected can be inadvertently embolized. Once all of 
the portal branches that supply the liver segments to be resected 
are confirmed, the most proximal sites of the portal vein branches 
in which embolic material can be placed are identified. These sites 
can vary depending on the portal vein branching anatomy, the 
length of the right portal vein, and the surgical techniques used 
for control of inflow to the liver, as discussed in the previous sec-
tion. The diameters of the portal branches to be embolized are 
measured to estimate the size of the occlusion balloon used or 
that of embolization coils to be placed. Finally, the distal branches 
of the portal venous system are assessed for safe portal access. If 
an ipsilateral approach is planned, the anticipated portal access 
tract should not transgress the tumor. If no ideal distal portal vein 
branch can be identified for access due to anatomical distortion 
of the portal vein branches from a large tumor or the presence of 
multiple tumors, then a contralateral approach might need to be 
considered.
TeCHNiQUeS AND TiPS FOR 
PeRCUTANeOUS Pve
Regardless of the different techniques and embolic materials used, 
PVE generally consists of five basic technical steps: (1) gaining 
access to the portal venous system, (2) flush portography and por-
tal pressure measurement, (3) catheterization of the portal vein 
branches within the liver segments to be resected and delivery 
of embolic material to the branches, (4) final flush portography 
and portal pressure measurement, and (5) removal of the devices 
used, with or without tract embolization. Knowledge of technical 
tips, potential complications, and how to avoid the complications 
in each step of PVE is of great importance to perform the proce-
dure safely and successfully.
The first step in PVE is to gain access to the portal venous 
system. Ultrasound is used to identify a suitable peripheral portal 
vein branch for safe access. It is the authors’ preference that the 
peripheral portal vein branch be punctured with a 22-gauge Chiba 
needle (Cook Medical, Bloomington, IN, USA) under ultrasound 
guidance. A metal introducer set (SKATER™ Introducer System, 
Angiotech, Gainesville, FL, USA) is then advanced into the portal 
vein branch over a 0.018″ guidewire, followed by placement of a 
5- or 6-Fr vascular sheath to establish portal access. The vascular 
sheath must be sufficiently long to reach the portal vein branch. 
Otherwise, access to the portal venous system will be lost when 
the guidewire or catheter is removed through the sheath. This 
step is associated with the majority of the bleeding complications 
that arise from percutaneous PVE, including hemoperitoneum, 
subcapsular hematoma, hepatic artery injury or pseudoaneurysm, 
and transient hemobilia (50, 51). If the puncture is made via an 
intercostal space, intercostal artery injury, hemothorax, or pneu-
mothorax can also occur. Meticulous preprocedural evaluation of 
the peripheral portal branches to identify safe access, minimizing 
the number of needle passes and using a 21- or 22-gauge needle, 
can reduce the chance of complications during this step. The next 
step involves flush portography and portal pressure measurement. 
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A 5-Fr flush angiographic catheter is introduced into the main 
portal vein over the guidewire. The catheter or guidewire that 
is inserted into the portal venous system must be manipulated 
as gently as possible so as not to cause any damage to the vessels 
that can result in thrombosis. This care is especially important 
when a contralateral approach is used. Flush portography is then 
performed to confirm the portal vein branching anatomy that was 
previously assessed with cross-sectional imaging and to deter-
mine the portal vein branches that must be embolized. At least 
two projections are often necessary to evaluate the portal vein 
branching anatomy fully; a craniocaudal or right anterior oblique 
projection is often added to an anterior–posterior projection for 
evaluation of the right posterior portal vein. Portal pressure is 
measured, especially in patients with cirrhosis, to confirm the 
absence of portal hypertension. Severe portal hypertension with 
a portosystemic pressure gradient greater than 12-mm Hg is a 
relative contraindication for major hepatic resection (52). If any 
portosystemic collaterals are identified (thus reflecting portal 
hypertension), the indication for PVE needs to be reconsidered. 
Once the portal vein branching anatomy and the absence of portal 
hypertension are confirmed, the portal branches within the liver 
segments to be resected are selected, and embolic materials are 
delivered until flow stasis is achieved. In the authors’ experience, 
where an ipsilateral approach is used, a 5-Fr reverse curved cath-
eter (Sos Omni, AngioDynamics, Inc., Queensbury, NY, USA) is 
used to select the right portal vein branches. The most proximal 
sites of the portal vein branches where embolic material can be 
placed can vary, depending on the portal branching anatomy 
and the technique used for the anticipated hepatic resection. As 
discussed in the prior section, care should be taken to leave an 
approximately 1-cm portion of the proximal right portal vein 
free of embolic material, as the inflammatory reaction caused by 
embolic material can make the surgical division or suture ligation 
difficult. In cases of planned extended right hepatectomy, several 
researchers have advocated embolization of Sg 4 (Figure  9) to 
maximize the hypertrophy of the FLR (Sg 2 and 3) (53, 54). This 
step is usually performed prior to right PVE because embolic 
materials placed within the previously embolized right liver can 
potentially dislodge to the FLR during embolization of Sg 4 (55). 
Potential complications during this step include non-targeted 
embolization and left portal vein thrombosis. While delivering 
the embolic material to the targeted vessels, care must be taken 
not to cause backflow of the embolic material to the FLR espe-
cially when the antegrade flow within the targeted vessel becomes 
sluggish. Left portal vein thrombosis is an especially serious 
complication, as it can preclude future hepatic resection (56). If 
the thrombus is acute and extensive, chemical thrombolysis with 
or without mechanical thrombectomy should be considered. 
After embolization is complete, a repeat portogram is obtained 
to confirm adequate embolization of the portal vein branches 
within the liver segments to be resected. The portal pressure is 
again measured to check for the presence of portal hypertension, 
which might be uncovered following the procedure. Normally, 
the portal pressure increases by 3–5 mm Hg. Great care must be 
exercised not to dislodge the embolic material delivered during the 
portography. Because of the potential risk of dislodging embolic 
material, we normally do not exchange the working 5-Fr catheter 
for a flush angiographic catheter prior to portography. Finally, 
the catheter is gently removed from the portal venous system, 
with care taken to avoid propagation of any embolic materials 
to the FLR. Embolization of the access tract with Gelfoam® or 
coils is optional but is commonly performed to prevent bleeding 
complications when an ipsilateral approach is used.
ADDiTiONAL STRATeGieS OR 
TeCHNiCAL MODiFiCATiONS FOR Pve
At times, additional strategies or technical modifications are 
required to accomplish preoperative PVE. Cases with complex 
portal vein branching anatomy can require selection and emboli-
zation of the individual variant portal vein branches (Figure 10). 
The portal branching anatomy must be meticulously assessed, and 
the portal access site should be carefully planned for easy cannu-
lation of all of the variant branches that must be embolized. With 
some portal vein branches, especially when branching variations 
are present, it is difficult to assess which segment the branches 
are supplying, even with portograms from multiple projections. 
In such situations, C-arm cone-beam CT can easily depict the 
segment that the portal vein branch in question is supplying 
and can help to avoid non-targeted embolization or to allow for 
confident embolization of the selected branch (Figure 11) (57). 
Large tumors can pose a challenge for portal access and complete 
embolization of the portal branches within the diseased liver 
because of distortion of the portal vein branches by the tumor. 
Access through the tumor should be avoided, as tumor puncture 
can potentially result in hemoperitoneum or tumor seeding. An 
initial plan of an ipsilateral approach might need to be changed to 
a contralateral approach during the procedure because few portal 
vein branches are accessible within the diseased liver (Figure 12).
SUMMARY
Preoperative PVE is used to extend the indications for major 
hepatic resection and has become the standard of care for selected 
patients with hepatic malignancies in major hepatobiliary centers. 
To date, various techniques, using different embolic materials, 
have been employed without significant differences in the degree 
of liver hypertrophy. Both surgeons and interventional radiolo-
gists must be familiar with the segmental anatomy of the liver, 
have a good knowledge of portal vein anatomy and branching 
variations, and understand the techniques used to ligate the por-
tal vein during planned hepatic resection because these variables 
can affect the PVE procedure and ultimately the surgical resec-
tion. Knowledge regarding the advantages and disadvantages of 
the approaches to the portal system and of the various embolic 
materials used for PVE is essential to best tailor the procedure 
and to avoid complications. Because PVE is used as an adjunct 
to planned hepatic resection, priority must always be placed on 
safety, without compromising the integrity of the FLR, and close 
collaboration between interventional radiologists and hepatobil-
iary surgeons is essential to achieve successful outcomes.
It is important to note that new innovative approaches are being 
developed that are variations on the standard PVE. For example, 
FiGURe 9 | Right Pve extended to segment 4. (A) Intraprocedural ultrasound image shows a 22-gauge Chiba needle (arrowheads) placed within the branch of 
the right portal vein. A metal introducer set was subsequently introduced into the right portal system over a 0.018 guidewire (not shown). (B) Flush portogram shows 
a 5-Fr pigtail catheter (arrow) introduced through a 6-Fr sheath (arrowhead) and placed within the main portal vein. No variant main portal vein branching is 
demonstrated. (C) Selective right portogram, using a 5-Fr reverse curved catheter, shows right portal vein branches. Note the metallic coils placed within the Sg 4 
branches. (D) Selective right portogram following delivery of PVA particles into the right portal vein branches shows embolized subsegmental branches within the 
right liver. (e) Final portogram shows successful embolization of the right portal vein and Sg 4 branches, with preserved blood flow to the FLR (Sg 2 and 3). Note the 
metallic coils placed within the proximal right anterior and posterior branches (arrowheads).
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FiGURe 10 | Right Pve in a patient with complex right portal vein branching anatomy. (A) Flush portogram shows the right posterior portal vein arising as 
the first branch of the main portal vein (large arrow). The Sg 7 branch arises from the proximal right posterior portal vein (small arrow). The common trunk (large 
arrowhead) of the left portal vein and the right anterior portal vein trifurcate into the left portal vein and two right anterior portal vein branches (small arrowheads). 
Based on this right portal vein branching anatomy, the four right portal vein branches are separately embolized with PVA particles and metallic coils. (B) Final 
portogram shows successful right PVE, with preserved blood flow to the left liver. Note the metallic coils placed in the proximal portion of each branch.
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FiGURe 11 | A questionable subsegmental portal vein branch crossing the midplane of the liver in a patient referred for right Pve. (A) Flush portogram 
shows a subsegmental branch directing to the left (small arrow) that is arising from the segmental branch directing to the dome of the liver (large arrow). (B) 
Selective right portogram clearly shows the subsegmental branch that possibly supplies segment 4 (small arrow). (C,D) Axial, (A) sagittal, and (B) reformatted C-arm 
cone-beam CT images during selective right portogram show the segmental branch supplying segment 7 (arrowheads). The subsegmental branch that was 
considered to be possibly supplying segment 4 was shown to be supplying segment 7. This segmental branch was then confidently embolized with PVA particles 
and coils. Note that artifact from the metallic coils placed in the right liver during the PVE procedure.
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FiGURe 12 | Right Pve via a contralateral approach in a patient with a large hepatocellular carcinoma. (A) Contrast-enhanced T1-weighted coronal MR 
images show a large tumor in the right liver. Marked distortions of the anterior (arrows) and posterior (arrowheads) branches of the right portal vein caused by the 
tumor are noted. The patient was referred for right PVE prior to a right hepatectomy. An ipsilateral approach was initially planned; however, no portal branches were 
identified for safe access within the right liver during the procedure. Access to the Sg4 portal vein branch was then obtained with a 22-gauge Chiba needle (not 
shown). (B) Flush portogram shows a 5-Fr pigtail catheter placed within the main portal vein through a 6-Fr sheath (arrow). (C) Final portogram shows successful 
occlusion of the right portal vein branches, with preserved blood flow to the left portal vein branches.
associating liver partition and portal vein ligation (ALPPS) is a 
technique involving hepatectomy in two stages. At the first stage, 
a hepatotomy through the anticipated resection plane is per-
formed while preserving the exposed vessels and the portal vein 
to the portion of liver to be resected is surgically ligated. The FLR 
hypertrophies much faster than with standard PVE, in 1–2 weeks, 
after which the hepatic resection can be completed. A faster 
hypertrophy is seen in this procedure compared with standard 
PVE due to inflammatory signals from both the embolization and 
from the laparotomy with hepatic transection. Although there 
are higher hypertrophy rates with ALPSS compared to standard 
PVE, the rates of morbidity and mortality are significantly higher, 
limiting the routine applications of this technique currently (58, 
59). Other approaches being investigated include radioemboliza-
tion as a treatment for liver tumors. A recent review described 
how radioembolization of tumors can result in hypertrophy of 
the contralateral lobe, albeit slower than with PVE (60). This 
has implications for preoperative treatment of liver tumors in a 
fashion similar to PVE, although allowing for treatment of the 
tumor while causing hypertrophy of the contralateral lobe.
Despite these alternatives, the gold standard method pres-
ently remains PVE as the optimal oncosurgical strategy to allow 
for hypertrophy of the contralateral liver and make potentially 
unresectable lesions resectable by better selection and lower risk 
of postoperative liver insufficiency or failure. This strategy is ideal 
for high volume centers and should be performed in a multidis-
ciplinary setting to allow for the highest chance of success for 
patients.
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